drugset / Trial / NCT01725360

Change of Airway Hyperresponsiveness to Mannitol and Methacholine in Patients With Asthma

NCT01725360

Phase 4 Completed 17 enrolled Cantonal Hosptal, Baselland
NaSingle-groupOpen-labelTreatment

Summary

Control of airway inflammation is the cornerstone of asthma management. The aim of the present pilot study was to assess whether, and in which magnitude, a leukotriene receptor antagonist (LTRA) added to a basic treatment of inhaled corticosteroids (ICS) + long-acting betamimetics (LABA) might improve airway hyperresponsiveness and inflammation in well-controlled patients with asthma.

Timeline

Start
2007-01
Primary completion
2011-12
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified 10 mg

Indications